DEC 09, 2020 6:00 AM PST

Antibodies as Warning Signs of a Silent Cardiovascular Killer

WRITTEN BY: Tara Fernandez

In atherosclerosis, cholesterol and other fatty deposits build up around the inner walls of an artery, creating a plaque that restricts blood flow. Plaques pose a double risk — they can detach from the artery causing a blood clot or lead to a heart attack or stroke. 

The problem is that plaques form gradually over years, without any symptomatic warning signs. The key to earlier interventions is the identification of biomarkers to alert physicians to the presence of atherosclerosis before it’s too late. In the United States, over 600,000 people die of heart disease every year, representing 1 in 4 deaths.

In a recent publication in Nature, scientists have made an important connection between atherosclerosis and the immune system, leading to the discovery of a new biomarker for the condition. 

One of the authors, Almudena Ramiro, said: "We know that atherosclerosis includes an immunological component and that the innate and adaptive immune systems are both involved in the origin and progression of this disease."

Ramiro and colleagues demonstrated that in atherosclerosis, the immune system recognizes a mitochondrial protein called ALDH4A1 as an autoantigen, producing antibodies against it.

"ALDH4A1 is recognized by the protective antibodies produced during atherosclerosis, making it a possible therapeutic target or diagnostic marker for this disease," said Ramiro.

Diving deeper into their hypothesis that ALDH4A1 antibodies could represent a viable diagnostic biomarker, the team performed a series of experiments in transgenic mice on a high-fat diet. They studied the immune repertoire of antibodies produced by these mice during atherosclerosis using high-throughput screening and gene sequencing.

"Analysis of the sequences of more than 1700 antibody genes showed that mice with atherosclerosis produced a distinct antibody repertoire. The production of these antibodies allowed us to study their targets (their antigen specificity) and their functional properties," said study collaborator Hedda Wardemann.

 

 

"The study shows that ALDH4A1 accumulates in plaques and that its plasma concentration is elevated in the atherosclerosis-prone mice and in human patients with carotid atherosclerosis, establishing ALDH4A1 as a possible biomarker of the disease," added Ramiro.

In another exciting finding, the team showed that ALDH4A1 antibodies could also be used as a preventative treatment or therapeutic. Administering these antibodies to mice delayed the development of plaques and also suppressed levels of circulating free cholesterol. 

"These results broaden our knowledge of the humoral response during atherosclerosis and highlight the potential of ALDH4A1 as a new biomarker and of A12 as a therapeutic agent for this disease," concludes Ramiro.

 

Sources: Nature, Medical Xpress


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 21, 2020
Immunology
The Perfect Storm: Wildfires, Flu and COVID-19
SEP 21, 2020
The Perfect Storm: Wildfires, Flu and COVID-19
Over 85 massive wildfires have swept through the West Coast, devastating communities in Washington, Oregon, and Californ ...
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
Loading Comments...